SCPHARMACEUTICALS INC (SCPH) Forecast, Price Target & Analyst Ratings

NASDAQ:SCPH • US8106481059

5.67 USD
0 (0%)
At close: Oct 6, 2025
5.77 USD
+0.1 (+1.76%)
After Hours: 10/6/2025, 9:01:22 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SCPHARMACEUTICALS INC (SCPH).

Forecast Snapshot

Consensus Price Target

Price Target
$12.33
+ 117.45% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release DateNov 5, 2025
PeriodQ3 / 2025
EPS Estimate-$0.24
Revenue Estimate20.051M
 → Full earnings forecast details

ChartMill Buy Consensus

Rating
76.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$12.33
Upside
+ 117.45%
From current price of $5.67 to mean target of $12.33, Based on 10 analyst forecasts
Low
$5.40
Median
$9.18
High
$26.25

Price Target Revisions

1 Month
0.00%
3 Months
-22.52%

Price Target Summary

10 Wall Street analysts provided a forecast for the next 12 months for SCPH. The average price target is 12.33 USD. This implies a price increase of 117.45% is expected in the next year compared to the current price of 5.67.
The average price target has been revised downward by 22.52% in the past 3 months.
 → Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

SCPH Current Analyst RatingSCPH Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

SCPH Historical Analyst RatingsSCPH Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
76.00%
SCPH was analyzed by 10 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about SCPH.
In the previous month the buy percentage consensus was at a similar level.
SCPH was analyzed by 10 analysts. More opinions would make the average more meaningful.
 → Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-08-26Craig-HallumDowngrade Buy -> Hold
2025-08-25Maxim GroupDowngrade Buy -> Hold
2025-03-20Maxim GroupMaintains Buy -> Buy
2025-03-20HC Wainwright & Co.Reiterate Buy -> Buy
2025-03-07HC Wainwright & Co.Reiterate Buy -> Buy
2025-03-03HC Wainwright & Co.Reiterate Buy -> Buy
2024-11-14Craig-HallumMaintains Buy -> Buy
2024-11-14HC Wainwright & Co.Reiterate Buy -> Buy
2024-08-19HC Wainwright & Co.Reiterate Buy -> Buy
2024-05-15HC Wainwright & Co.Reiterate Buy -> Buy
2024-03-14HC Wainwright & Co.Reiterate Buy -> Buy
2023-09-07Craig-HallumInitiate Buy
2023-08-11HC Wainwright & Co.Reiterate Buy -> Buy
2023-08-02HC Wainwright & Co.Reiterate Buy -> Buy
2023-07-19HC Wainwright & Co.Reiterate Buy -> Buy
2023-06-08HC Wainwright & Co.Reiterate Buy -> Buy
2023-05-11Maxim GroupMaintains Buy -> Buy
2023-05-11HC Wainwright & Co.Reiterate Buy -> Buy
2023-03-23HC Wainwright & Co.Reiterate Buy
2023-01-27SVB LeerinkMaintains Outperform
2022-12-01Cowen & Co.Initiate Outperform
2022-11-10SVB LeerinkMaintains Outperform
2022-11-10HC Wainwright & Co.Maintains Buy
2022-10-11SVB LeerinkUpgrade Market Perform -> Outperform
2022-08-02Maxim GroupInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release DateNov 5, 2025
PeriodQ3 / 2025
EPS Estimate-$0.24
Revenue Estimate20.051M
Revenue Q2Q99.99%
EPS Q2Q68.38%
Number of Analysts6

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
-4.60%
EPS (1 Month)
0.00%
EPS (3 Months)
5.49%

Next Earnings Summary

SCPH is expected to report earnings on 11/5/2025. The consensus EPS estimate for the next earnings is -0.24 USD and the consensus revenue estimate is 20.05M USD.
The next earnings revenue estimate has been revised downward by 4.6% in the past 3 months.
 → Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
SCPH revenue by date.SCPH revenue by date.
13.593M36.332M
167.28%		74.226M
104.30%		130.68M
76.06%		189.98M
45.38%		246.51M
29.76%		301.49M
22.30%		364.83M
21.01%		477.91M
31.00%		543.89M
13.81%
EBITDA
YoY % growth
SCPH ebitda by date.SCPH ebitda by date.
-36.12M
-40.05%		-54.77M
-51.63%		-64.628M
-18.00%		-53.754M
16.83%		-9.894M
81.59%		26.724M
370.10%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
SCPH ebit by date.SCPH ebit by date.
-36.16M
-40.05%		-55.396M
-53.20%		-64.776M
-16.93%		-55.023M
15.06%		-5.469M
90.06%		41.946M
866.91%		86.926M
107.23%		127.1M
46.22%		177.66M
39.78%		278.81M
56.93%		331.72M
18.98%
Operating Margin
SCPH operating margin by date.SCPH operating margin by date.
N/A-407.53%-178.29%-74.13%-4.19%22.08%35.26%42.16%48.70%58.34%60.99%
EPS
YoY % growth
SCPH eps by date.SCPH eps by date.
-1.30
-26.21%		-1.42
-9.23%		-1.90
-33.80%		-1.11
41.66%		-0.16
85.28%		0.68
515.63%		1.29
90.48%		1.85
43.42%		2.61
41.10%		4.19
60.34%		4.69
11.92%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.24
68.38%		-0.17
50.46%		-0.11
71.05%		-0.11
67.00%		-0.06
74.19%		-0.04
76.47%
Revenue
Q2Q % growth		20.051M
99.99%		26.102M
114.83%		26.928M
129.14%		28.764M
79.32%		30.447M
51.85%		34.425M
31.89%
EBITDA
Q2Q % growth		-10.506M
41.82%		-7.65M
52.76%		-6.222M
64.84%		-4.488M
68.32%		-1.122M
89.32%		102K
101.33%
EBIT
Q2Q % growth		-12.232M
32.59%		-8.62M
47.26%		-6.732M
62.09%		-4.998M
65.03%		-1.836M
84.99%		1.632M
118.93%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

SCPH Yearly Revenue VS EstimatesSCPH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M 500M
SCPH Yearly EPS VS EstimatesSCPH Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 -2 4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
33.08%
EPS Next 5 Year
24.37%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
72.57%
Revenue Next 5 Year
52.16%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
33.96%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

SCPHARMACEUTICALS INC / SCPH Forecast FAQ

What is the average price target for SCPHARMACEUTICALS INC (SCPH) stock?

10 analysts have analysed SCPH and the average price target is 12.33 USD. This implies a price increase of 117.45% is expected in the next year compared to the current price of 5.67.


When does SCPHARMACEUTICALS INC (SCPH) report earnings?

SCPHARMACEUTICALS INC (SCPH) will report earnings on 2025-11-05, after the market close.


Can you provide the consensus estimates for SCPHARMACEUTICALS INC next earnings?

The consensus EPS estimate for the next earnings of SCPHARMACEUTICALS INC (SCPH) is -0.24 USD and the consensus revenue estimate is 20.05M USD.


What is the consensus rating for SCPH stock?

The consensus rating for SCPHARMACEUTICALS INC (SCPH) is 76 / 100 . This indicates that analysts generally have a positive outlook on the stock.